GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bonesupport Holding BONEX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

324.20

+1.12%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 1.17bn

FY2016FY2025

Net income

SEK 142.2m

FY2016FY2025

Free cash flow

SEK 216.1m

FY2016FY2025

Shareholders' equity

SEK 867.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 1.17bnSEK 898.7mSEK 591.1mSEK 328.8mSEK 212.9mSEK 180.9mSEK 155.5mSEK 96.6mSEK 129.3mSEK 104.6m
Gross profitSEK 1.09bnSEK 832.3mSEK 540.9mSEK 300.8mSEK 190.0mSEK 161.6mSEK 135.9mSEK 81.5mSEK 112.4mSEK 88.3m
Research and developmentSEK 91.4mSEK 76.0mSEK 57.1mSEK 53.1mSEK 53.0mSEK 57.9mSEK 68.9mSEK 66.1mSEK 60.6mSEK 38.2m
Operating incomeSEK 276.7mSEK 166.1mSEK 15.8m−SEK 64.5m−SEK 80.7m−SEK 98.6m−SEK 158.1m−SEK 173.8m−SEK 99.3m−SEK 88.7m
Net incomeSEK 142.2mSEK 133.8mSEK 245.0m−SEK 68.2m−SEK 85.5m−SEK 101.4m−SEK 161.1m−SEK 176.4m−SEK 128.9m−SEK 110.2m
Diluted earnings per share2.132.003.70-1.06-1.33-1.59-3.08-3.41-2.55-2.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 1.04bnSEK 879.7mSEK 688.8mSEK 371.8mSEK 343.9mSEK 465.2mSEK 196.3mSEK 326.1mSEK 596.7mSEK 188.8m
Cash and short-term investmentsSEK 378.0mSEK 227.0mSEK 167.4mSEK 201.3mSEK 206.5mSEK 353.7mSEK 92.1mSEK 261.5mSEK 533.4mSEK 141.5m
Total liabilitiesSEK 168.9mSEK 152.2mSEK 143.6mSEK 102.9mSEK 78.2mSEK 66.3mSEK 72.0mSEK 47.6mSEK 145.9mSEK 154.5m
DebtSEK 11.7mSEK 14.6mSEK 17.5mSEK 17.5mSEK 21.4mSEK 10.5mSEK 10.4m—SEK 98.6mSEK 109.7m
Shareholders' equitySEK 867.3mSEK 727.5mSEK 545.2mSEK 268.9mSEK 265.7mSEK 398.9mSEK 124.3mSEK 278.5mSEK 450.8mSEK 34.3m
Shares outstanding67m67m66m65m64m64m52m52m51m46m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 221.3mSEK 65.8m−SEK 18.3m−SEK 47.0m−SEK 83.4m−SEK 100.3m−SEK 163.8m−SEK 171.6m−SEK 107.5m−SEK 81.9m
Capital spending−SEK 5.2m−SEK 5.8m−SEK 6.1m−SEK 2.0m−SEK 3.4m−SEK 2.7m−SEK 4.4m−SEK 2.6m−SEK 4.6m−SEK 1.4m
Free cash flowSEK 216.1mSEK 59.9m−SEK 24.3m−SEK 48.9m−SEK 86.8m−SEK 102.9m−SEK 168.3m−SEK 174.2m−SEK 112.1m−SEK 83.3m
Dividends paid————−SEK 5.5m—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 355.7mSEK 324.0mSEK 312.5mSEK 294.1mSEK 284.4mSEK 283.5mSEK 257.0mSEK 237.5m
Gross profitSEK 323.0mSEK 298.9mSEK 289.0mSEK 273.2mSEK 262.6mSEK 262.5mSEK 238.0mSEK 220.6m
Operating incomeSEK 89.6mSEK 72.2mSEK 79.6mSEK 71.0mSEK 54.9mSEK 29.6mSEK 64.2mSEK 41.0m
Net incomeSEK 81.9mSEK 53.4mSEK 44.1mSEK 34.5mSEK 53.1mSEK 10.4mSEK 53.9mSEK 30.6m
Diluted earnings per share1.230.800.660.520.790.160.810.46
Cash from operationsSEK 67.0mSEK 74.0mSEK 53.0mSEK 71.0mSEK 49.0mSEK 46.0mSEK 73.0mSEK 42.0m
Capital spending−SEK 2.0m———−SEK 1.0m—−SEK 1.0m—
Free cash flowSEK 65.0m———SEK 48.0m—SEK 72.0m—
Total assetsSEK 1.12bnSEK 1.12bnSEK 1.04bnSEK 1.01bnSEK 962.8mSEK 896.1mSEK 879.7mSEK 778.6m
Cash and short-term investmentsSEK 434.3mSEK 455.3mSEK 378.0mSEK 379.0mSEK 309.7mSEK 267.1mSEK 227.0mSEK 153.2m
DebtSEK 7.7mSEK 8.0mSEK 11.7mSEK 11.3mSEK 12.7mSEK 12.7mSEK 14.6mSEK 6.4m
Shareholders' equitySEK 949.7mSEK 938.9mSEK 867.3mSEK 835.9mSEK 796.7mSEK 740.8mSEK 727.5mSEK 661.8m

Financial ratios

Data as of 3 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin92.6%92.6%91.5%91.5%89.3%89.4%
Operating margin23.6%18.5%2.7%-19.6%-37.9%-54.5%
Net margin12.1%14.9%41.5%-20.7%-40.2%-56.1%
Return on equity16.4%18.4%44.9%-25.3%-32.2%-25.4%
Return on assets13.7%15.2%35.6%-18.3%-24.9%-21.8%
Free cash flow yield1.5%0.5%-0.1%-0.3%-0.6%-0.7%
Revenue growth30.7%52.0%79.8%54.5%17.7%16.3%
Earnings growth6.3%-45.4%-459.4%-20.3%-15.7%-37.0%
Current ratio4.85x4.32x3.10x3.76x5.00x7.31x
Debt to equity0.01x0.01x0.01x0.02x0.02x0.01x
Equity ratio83.7%82.7%79.1%72.3%77.3%85.7%
Interest coverage82.93x72.43x5.08x-66.53x-69.07x-221.49x
R&D as a share of sales7.8%8.5%9.7%16.1%24.9%32.0%
Buybacks as a share of market value0.1%-0.9%-2.7%-0.3%-0.9%-21.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue52.9%45.4%34.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin92.6%92.2%91.9%91.1%
Operating margin21.4%13.2%6.3%-9.1%
Net margin13.3%15.1%7.8%-9.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings88.3193.250.9-76.2-33.1-24.7-5.3-3.0-3.9
Price to sales10.728.821.115.813.313.95.55.53.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.